HIGD2A and hepatocellular carcinoma: Our study determined that knockdown of HIGD2A suppressed the proliferation and growth of HCC cells by interfering with the MAPK/ERK pathway and suggested that HIGD2A may play a role in abnormal mitochondrial metabolism in HCC.